Posts for Aptorum Group Ltd ($APM)

Showing 1 - 2 of 2 Posts

Aptorum Group Limited's $3M Direct Offering Report: Key Highlights & Insights

•

Form 6-K

•

2025-01-07

Last updated: 4 months ago

Aptorum Group Limited's $3M Direct Offering Report: Key Highlights & Insights

Explore Aptorum Group Limited's financial report detailing a $3M direct offering, share sale, usage of proceeds, and regulatory compliance insights. Key for investors!

biotechnology capital raising research and development financial reporting public offerings

Aptorum Group Limited Q2 2024 Financial Report: Losses & Future Challenges

•

Form 6-K

•

2024-12-20

Last updated: 5 months ago

Aptorum Group Limited Q2 2024 Financial Report: Losses & Future Challenges

Explore Aptorum Group's Q2 2024 financials: $2.6M net loss, zero revenue, and merger termination impacts. Caution advised.

biotechnology financial analysis Aptorum Group healthcare investment operational challenges